HIV and hepatitis C virus coinfection in Canada: challenges and opportunities for reducing preventable morbidity and mortality-Reference-Cited by-同舟云学术

HIV and hepatitis C virus coinfection in Canada: challenges and opportunities for reducing preventable morbidity and mortality

Published:2012-05-28 Issue:1 Volume:14 Page:10-20
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Med

Author:

Klein MB¹,Rollet KC¹,Saeed S¹,Cox J,Potter M¹,Cohen J²,Conway B³,Cooper C⁴,Côté P⁵,Gill J⁶,Haase D⁷,Haider S⁸,Hull M⁹,Moodie E¹⁰,Montaner J⁹,Pick N¹¹,Rachlis A¹²,Rouleau D¹³,Sandre R¹⁴,Tyndall M,Walmsley S¹⁵,

Affiliation:

1. Department of Medicine, Divisions of Infectious Diseases/Immunodeficiency; Royal Victoria Hospital, McGill University Health Centre; Montreal; QC; Canada

2. Windsor Regional Hospital Metropolitan Campus; Windsor; ON; Canada

3. Department of Pharmacology and Therapeutics; University of British Columbia, Faculty of Medicine; Vancouver; BC; Canada

4. Department of Medicine, Division of Infectious Diseases; University of Ottawa; Ottawa; ON; Canada

5. Clinique Médicale du Quartier Latin; Montreal; QC; Canada

6. Southern Alberta HIV Clinic; Calgary; AB; Canada

7. Capital District Health Authority, Dalhousie University; Halifax; NS; Canada

8. McMaster University; Hamilton; ON; Canada

9. BC Centre for Excellence in HIV/AIDS and the University of British Columbia; Vancouver; BC; Canada

10. Department of Epidemiology, Biostatistics and Occupational Health; McGill University; Montreal; Canada

11. Oak Tree Clinic, Children's and Women's Health Centre of British Columbia; University of British Columbia; Vancouver; BC; Canada

12. Sunnybrook Health Sciences Centre; University of Toronto; Toronto; ON; Canada

13. Centre Hospitalier de l'Université de Montréal, Université de Montréal; Département de Microbiologie et Immumunologie; Montreal; QC; Canada

14. HAVEN group; Hôpital Régional de Sudbury Regional Hospital (HRSRH); Sudbury; ON; Canada

15. University Health Network; University of Toronto; ON; Canada

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1468-1293.2012.01028.x/fullpdf

Reference40 articles.

1. Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens;Hogg;CMAJ,1999

2. Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy;Lima;AIDS,2007

3. Health care costs associated with hepatitis C: a longitudinal cohort study;Krajden;Can J Gastroenterol,2010

4. Comorbidities associated with the increasing burden of hepatitis C infection;Basseri;Liver Int,2010

5. The global burden of hepatitis C;Lavanchy;Liver Int,2009

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Severe liver fibrosis in the HCV cure era: Major effects of social vulnerability, diabetes, and unhealthy behaviors;JHEP Reports;2022-06

2. Differences in risk factors for hepatitis B, hepatitis C, and human immunodeficiency virus infection by ethnicity: A large population-based cohort study in British Columbia, Canada;International Journal of Infectious Diseases;2021-05

3. Estimating an individual-level deprivation index for HIV/HCV coinfected persons in Canada;PLOS ONE;2021-04-19

4. COVID-19 epidemiology in Canada from January to December 2020: the pre-vaccine era;FACETS;2021-01-01

5. HCV-infected individuals have higher prevalence of comorbidity and multimorbidity: a retrospective cohort study;BMC Infectious Diseases;2019-08-23